05:12 PM EDT, 06/16/2025 (MT Newswires) -- Enliven Therapeutics ( ELVN ) said late Monday it has closed its public offering of shares and pre-funded warrants, raising about $230 million for the clinical-stage drugmaker.
The closing includes the full exercise of its over-allotment option, according to the company.